Randomised trial on clinical performances and biocompatibility of four high-flux hemodialyzers in two mode treatments: hemodialysis vs post dilution hemodiafiltration

被引:13
作者
Morena, Marion [1 ]
Creput, Caroline [3 ]
Bouzernidj, Mouloud [4 ]
Rodriguez, Annie [5 ,6 ]
Chalabi, Lotfi [6 ]
Seigneuric, Bruno [7 ]
Lauret, Celine [1 ]
Bargnoux, Anne-Sophie [1 ]
Dupuy, Anne-Marie [5 ]
Cristol, Jean-Paul [1 ,2 ]
机构
[1] Univ Montpellier, CNRS, Dept Biochim & Hormonol, PhyMedExp,INSERM,CHU Montpellier, Montpellier, France
[2] Inst Rech & Format Dialyse, Montpellier, France
[3] AURA, Serv Nephrol, Paris, France
[4] Clin Hemera Pays Caux, Serv Nephrol, Yvetot, France
[5] Univ Montpellier, Dept Biochim & Hormonol, CHU Montpellier, Montpellier, France
[6] AIDER, Montpellier, France
[7] CHU Toulouse, Serv Nephrol, Toulouse, France
关键词
ALL-CAUSE MORTALITY; ONLINE HEMODIAFILTRATION; VOLUME; EFFICIENCY; BETA-2-MICROGLOBULIN; QUANTIFICATION; DIALYZERS; MEMBRANES; LEVEL;
D O I
10.1038/s41598-019-54404-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This prospective multicenter randomized comparative cross-over trial aimed at evaluating the influence of hemodialysis vs post-dilution hemodiafiltration with high-flux dialyzers in solute clearance and biocompatibility profile. 32 patients were sequentially dialyzed with Leoceed-21HX, Polypure-22S+, Rexsys-27H and VIE-21A. Primary outcome was beta 2-microglobulin removal. Secondary outcomes were (i) extraction of other uremic solutes (ii) parameters of inflammation and nutrition and (iii) comparative quantification of perdialytic albumin losses (using total 'TDC' vs partial 'PDC' collection of dialysate). Significant increases in removal rates of beta 2-microglobulin (84.7 +/- 0.8 vs 71.6 +/- 0.8 mg/L), myoglobin (65.9 +/- 1.3 vs 38.6 +/- 1.3 mu g/L), free immunoglobulin light chains Kappa (74.9 +/- 0.8 vs 55.6 +/- 0.8 mg/L), beta-trace protein (54.8 +/- 1.3 vs 26.8 +/- 1.4 mg/L) and orosomucoid (11.0 +/- 1.1 vs 6.0 +/- 1.1 g/L) but not myostatin (14.8 +/- 1.5 vs 13.0 +/- 1.5 ng/mL) were observed in HDF compared to HD when pooling all dialyzers. Rexsys and VIE-A use in both HD and HDF subgroups was associated to a better removal of middle/large-size molecules compared to Leoceed and Polypure, except beta 2-microglobulin for Rexsys. Inflammatory parameters were unchanged between dialyzers without any interaction with dialysis modality. Mean dialysate albumin loss was comparable between TDC and PDC (1.855 vs 1.826 g/session for TDC and PDC respectively). In addition, a significant difference in albumin loss was observed between dialyzers with the highest value (4.5 g/session) observed using Rexsys. Use of all dialyzers was associated with good removals of the large spectrum of uremic toxins tested and good biocompatibility profiles, with an additional gain in removal performances with HDF. Larger surface area, thinner wall and resultant very high ultrafiltration coefficient of Rexsys should be taken into account in its clear performance advantages.
引用
收藏
页数:13
相关论文
共 37 条
  • [1] Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry
    Abe, Masanori
    Hamano, Takayuki
    Wada, Atsushi
    Nakai, Shigeru
    Masakane, Ikuto
    [J]. PLOS ONE, 2017, 12 (09):
  • [2] Precise quantification of dialysis using continuous sampling of spent dialysate and total dialysate volume measurement
    Argiles, A
    Ficheux, A
    Thomas, M
    Bosc, JY
    Kerr, PG
    Lorho, R
    Flavier, JL
    Stec, F
    Adele, C
    Leblanc, M
    Garred, LJ
    Canaud, B
    Mion, H
    Mion, CM
    [J]. KIDNEY INTERNATIONAL, 1997, 52 (02) : 530 - 537
  • [3] BERGSTROM J, 1987, LANCET, V1, P628
  • [4] Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients
    Bourguignon, Chlo
    Chenine, Leila
    Bargnoux, Anne Sophie
    Leray-Moragues, Helene
    Canaud, Bernard
    Cristol, Jean-Paul
    Morena, Marion
    [J]. JOURNAL OF NEPHROLOGY, 2016, 29 (02) : 251 - 257
  • [5] Canaud B, 2007, CONTRIB NEPHROL, V158, P110, DOI 10.1159/000107241
  • [6] Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS
    Canaud, B.
    Bragg-Gresham, J. L.
    Marshall, M. R.
    Desmeules, S.
    Gillespie, B. W.
    Depner, T.
    Klassen, P.
    Port, F. K.
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (11) : 2087 - 2093
  • [7] Evaluation of high-flux hemodiafiltration efficiency using an on-line urea monitor
    Canaud, B
    Bosc, JY
    Leblanc, M
    Garred, LJ
    Vo, T
    Mion, C
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (01) : 74 - 80
  • [8] Canaud B., 2016, EMC NEPHROLOGIE, V13, P1
  • [9] Canaud B, 2008, CONTRIB NEPHROL, V161, P191, DOI 10.1159/000130677
  • [10] Canaud B, 2007, CONTRIB NEPHROL, V158, P216, DOI 10.1159/000107253